The bowel management system can be defined as a device that enables the diversion of stool, which might be watery or semi-solid, and provides containment. It is employed in patients with fecal incontinence, constipation, in patients who have undergone spinal cord surgeries, and other neurological disorders. In children, these devices are primarily utilized in patients with spina bifida and anorectal disorders.
The global Bowel Management Systems Market was valued at US$ 1,682.95 Mn in 2017 and is anticipated to reach US$ 2,359.86 Mn by 2026, expanding at a CAGR of about 3.7% from 2018 to 2026. Expansion of the market can be attributed to the rising geriatric population in whom fecal incontinence and constipation is a common issue, rising prevalence of fecal incontinence, increase in the number of spinal cord surgeries performed annually, rise in awareness among people related to the advantages of bowel management systems, and the decline in skin infections owing to the use of these devices are driving the market. Furthermore, increasing longevity among the population, owing to the decline in the mortality rate, leading to the changing population demographics also fuels the market. However, demand from patients for non-invasive mode of treatment of bowel problems, which is considered as a conservative mode of treatment, the social stigma associated with the usage of these devices, and the contraindications on the use of these devices are likely to hamper the market.
In terms of product, the market has been segmented into systems and accessories. The systems segment has been further sub-segmented into irrigation systems, sacral neuromodulation systems, and others. The accessories segment has been further split into plugs, catheters, implants, anal sphincters, stool bags, and others. The systems segment is anticipated to expand at a significant growth rate during the forecast period, owing to the rise in demand for irrigation systems. Furthermore, these systems are designed for single-use, and are provided with catheters, bags and other related accessories. Rise in demand for irrigation systems can be attributed to their minimally invasive mode of treatment, the advantages of the use of these devices such as infection control, prevention of skin breakdown, odor prevention, and fast recovery. Usage of these devices enables patients to enhance the quality of their lives, lower the cost of daily management, and reduce nursing time.
Request to View Sample of Report –
Based on patient type, the market has been segregated into adult and pediatric. The adult segment is expected to expand at a steady pace during the forecast period. This can be attributed to the rising geriatric population owing to the increased longevity due to the decline in the mortality rates. Fecal incontinence (FI) is a common symptom in the geriatric population owing to various factors such as dementia, medications, neuromuscular dysfunction, and stool impaction. Additionally, constipation is known to be highly prevalent in geriatric population with a prevalence of over 50% in community dwelling geriatric population, and more than 75% in nursing home residents. Rise in FI and constipation in the geriatric population fuels the bowel management systems market, as fecal management systems (FMS) is considered to be an effective mode of treatment for FI and constipation.
In terms of end-user, the market has been classified into hospitals, ambulatory surgical centers, and home-care settings. The hospitals segment dominated the market in 2017; however, the home-care settings segment is expected to propel at a high CAGR during the forecast period and dominate the market in the near future. Expansion of the segment can be attributed to the cost effectiveness of treatment at home and the rise in demand from the patients for bowel management at home in order to avoid social stigma.
In terms of region, the market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe, cumulatively, accounted for more than 76% of the global market and are anticipated to remain dominant, in terms of revenue, in the near future. This can be attributed to the enhanced healthcare facilities available in these regions. In Europe, certain products, such as Axonics’ rechargeable Sacral Neuromodulation System (r-SNS), are approved for the treatment of fecal incontinence, which fuel the market. This product is still in the clinical trial stages in the U.S. The market in Asia Pacific is anticipated to expand at a robust pace during the forecast period. Expansion of the market in the region is expected to be contributed by the rising geriatric population in India and Japan.
Request to View Brochure of Report –
Key companies operating in the global bowel management systems market include Coloplast A/S, Medtronic plc, ConvaTec Group Plc, Hollister Incorporated, Cogentix Medical, Inc. (acquired by LABORIE Medical Technologies), Consure Medical, ProSys International Ltd., Aquaflush Medical Limited, C. R. Bard, Inc. (acquired by Becton, Dickinson and Company), B. Braun Melsungen AG, Respiratory Technology Corporation, MBH International A/S, Wellspect Healthcare (Part of Dentsply Sirona Company), and Axonics Modulation Technologies.